Umbilical Cord-Derived Mesenchymal Stem Cells Infusion in Type 2 Diabetes Mellitus Patients: A Retrospective Cytopeutics' Registry Study.

However, among patients with higher inflammation (hs-CRP ≥1.50 mg/L), hs-CRP showed a trend of decrease, going from 6.58±1.16 mg/L at baseline to 4.98±0.82 mg/L at the 6-month follow-up (p=0.073), while a significant decrease from 3.39 [4.41] mg/L at baseline to 1.45 [3.16] mg/L at the 12-month follow-up (p=0.016), falling within the normal range (reference range: ≤3.00 mg/L) ( Table 3 and Figure 5 ).

also in 53,322 other papers

FBS exhibited a decreasing trend over 6-months, although this was not statistically significant (p=0.086) ( Figure 2B ).

also in 47,180 other papers